Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

10 May 2016 - 16 May 2016
11 May 2016 - 13 May 2016

New Strategy to Enhance Multiple Sclerosis Treatment and Other Disorders

By BiotechDaily International staff writers
Posted on 28 May 2013
Print article
Working with laboratory mice models of multiple sclerosis (MS), scientists have identified a new molecular target for the design of drugs that could be safer and more effective than current US Food and Drug Administration (FDA)-approved medications against MS.

The research study’s findings, published online May 17, 2013, in the journal EMBO Molecular Medicine could have therapeutic applications for MS as well as cerebral palsy and leukodystrophies, all disorders associated with loss of white matter.

The target, a protein called mitochondrial translocator protein (TSPO), had been earlier identified but not tied to MS, an autoimmune disorder that peels off the protective fatty coating off nerve fibers of the brain and spinal cord. The mitrochronical TSPO is situated on the outer surface of mitochondria, cellular structures that supply energy to the cells. Damage to the fatty coating, or myelin, slows the transmission of the nerve signals that enable body movement as well as sensory and cognitive functioning.

The University of California (UC) Davis (Sacramento, USA) scientists identified mitochondrial TSPO as a potential therapeutic target when mice that had symptoms of MS improved after being treated with the antianxiety drug etifoxine, which interacts with mitochondrial TSPO. When etifoxine, a drug clinically available in Europe, was given to the MS laboratory mice before they had clinical symptoms of disease, the severity of the disease was decreased when compared to the untreated lab animals. When treated at the peak of disease severity, the animals’ MS symptoms improved.

“Etifoxine has a novel protective effect against the loss of the sheath that insulates the nerve fibers that transmit the signals from brain cells,” said Dr. Wenbin Deng, lead investigator of the study and associate professor of biochemistry and molecular medicine at UC Davis. “Our discovery of etifoxine’s effects on an MS animal model suggests that mitochondrial TSPO represents a potential therapeutic target for MS drug development. Drugs designed to more precisely bind to mitochondrial TSPO may help repair the myelin sheath of MS patients and thereby even help restore the transmission of signals in the central nervous system that enable normal motor, sensory and cognitive functions,” he said.

Dr. Deng added that better treatments for MS and other demyelinating diseases are needed, especially since current FDA-approved therapies do not repair the damage of immune attacks on the myelin sheath.

The investigators hope to additionally study the therapeutic applications of mitochondrial TSPO in drug development for MS and other autoimmune disorders. To identify more effective and safer drug candidates, they plan to pursue research grants that will enable them to evaluate a range of pharmacologic agents that bind to mitochondrial TSPO and other molecular targets in research models of MS and other myelin diseases.

Related Links:

University of California, Davis



Print article

Channels

Genomics/Proteomics

view channel
Image: Drop-inoculation of Saccharomyces cerevisiae mutants on an agar plate. The assay compares the viability of different yeast mutants (Photo courtesy of Wikimedia Commons).

Defective Genome Instability Suppressing Genes May Cause Some Types of Cancer

Cancer researchers reported in a recent study that defects in the expression of genes that suppress gross chromosomal rearrangements (GCRs) were linked to more than 93% of the ovarian and 66% of the colorectal... Read more

Biochemistry

view channel
Image: Scientists had viewed ant antennae as being used only to receive information – new research has demonstrated that they also transmit critical social signals (Photo courtesy of the University of Melbourne).

Ant Antennae Communicate Vital Social ID Information

Scientists have shone new light on the complexities of insect communication with the discovery that ants not only pick up information through their antennae, but also use them to convey social signals.... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more

Business

view channel

DNA Synthesis Specialists Acquire Advanced Software Design Capabilities

An American biotech firm that develops and produces synthetic DNA has established an international presence by purchasing an Israeli genetic design software company. Twist Bioscience Corporation (San Francisco, CA, USA), a company specializing in rapid, high-quality DNA synthesis, announced that Genome Compiler Corporation... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.